The Conjugation and Labeling Services Market Size is predicted witness at an 8.62% CAGR during the forecast period for 2023-2031.
Conjugation is the process of forming a stable hybrid using molecules such as a protein, antibody, peptide, or small molecule. These molecules can be conjugated with various modalities such as haptens, enzymes, carrier proteins, polymers, particle conjugates, isotopes, fluorescent labels, etc.
Biological research requires molecular labels covalently attached to a protein of interest to facilitate the detection or purification of the labeled protein and/or its binding partners. Currently, various labeling approaches (fluorescence labeling and isotopic labeling) are used by industrial entities for protein profiling to quantify compounds and to monitor and study biological processes.
The pharmaceutical industry widely uses conjugation and Labeling Services in several application areas, such as the development of conjugated drugs, drug delivery systems, disease diagnosis, the invention of diagnostic tools, and high-throughput screening. Due to the high demand for conjugated biomolecules in the field of research and development, multiple players worldwide are actively engaged in providing efficient antibody conjugation services. Thus, the increasing demand for conjugation and labeling services is projected to drive the market in the upcoming future.
Competitive Landscape:
Some of the Key Players in the Conjugation and Labeling Services Market:
- AltaBioscience
- Bachem
- Bio-Synthesis
- Cayman Chemical
- CliniSciences
- Eurogentec
- GBI
- Mimotopes
- Peptide Institute
- piCHEM
- Other Prominent Players
Market Segmentation:
The Conjugation and Labeling Services Market is segmented based on molecules, molecular conjugates/labels, and region. The molecules segment consists of proteins, peptides, small molecules, antibodies, and other molecules. By molecular conjugates/labels, the market is categorized into polymers, haptens, enzymes, fluorescent tags, bead coupling/particle conjugates, quantum dots, isotopes, and other molecular conjugates/labels.
The Antibodies Segment Accounted for the Largest Revenue Share of the Conjugation and Labeling Services Market in 2022
Antibody labeling, also called antibody conjugation, involves conjugating a tag to an antibody. Rising funding in R&D, increasing launches of novel customized antibody services by companies and the advantages of using antibodies for various applications are considered to provide lucrative growth to the market during the forecast period.
The Fluorescent Tags Segment Witnessed the Fastest Growth
Fluorescent tags of various types are used to stain or chemically label proteins, nucleic acids and other biomolecules. These tags are also helpful in detecting target antigens or interaction partners in applications, including cell imaging, flow cytometry, high-content analysis, western blotting, and ELISA.
Fluorescent labels do not require additional reagents for detection. This feature makes Fluorescent molecules remarkably versatile and the new standard in detecting protein location and activation, identifying complex protein formation & conformational changes and monitoring biological processes. Hence, the Fluorescent Tags segment is expected to proliferate in the global Conjugation and Labeling Services Market over the projected period.
Regionally, North America Holds the Highest Revenue Share
North America Conjugation and Labeling Services Market position is anticipated to record the highest market share revenue during the forecast period. The increasing number of companies offering protein labeling, peptide labeling, antibody conjugation and small molecule conjugation services are accelerating the growth of the regional market.
Conjugation and Labeling Services Market Report Scope:
Report Attribute |
Specifications |
Growth Rate CAGR |
CAGR of 8.62 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Molecules, By Molecular Conjugates/Labels |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
AltaBioscience, Bachem, Bio-Synthesis, Cayman Chemical, CliniSciences, Eurogentec, GBI, Mimotopes, Peptide Institute, piCHEM, and Others |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |